XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
NOte 7 - Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
   

January

2023

   

March

2023

 

Conversion price before

  $ 6.30     $ 2.87  

Conversion price after

  $ 2.87     $ 2.65  

Term (years)

    0.09       0.78  

Volatility

    167 %     168.9 %

Dividend rate

    0 %     0 %

Risk free rate

    4.46 %     4.20 %
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   

2023

   

2022

 

Common stock equivalents of convertible promissory notes and accrued interest

    2,946,525       157,139  

Warrants – other

    1,253,387       14,518  

Stock options

    6,400       8,147  

Total

    4,206,312       179,804  
Schedule of Warrant Activity [Table Text Block]
   

Number of

Shares

   

Weighted-Average

Exercise Price Per

Share

   

Weighted-

Average

Remaining

Contract Term

 

Balance at December 31, 2022

    340,689     $ 19.40       1.90  

Warrants granted

    1,071,429                  

Pre-funded warrants granted

    946,429                  

Warrants exercised

    (158,731 )                

Exercisable and Outstanding at March 31, 2023

    2,199,816     $ 3.84       2.56  
Warrants [Member]  
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
   

March

2023

 

Conversion price before

  $ 6.30  

Conversion price after

  $ 2.65  

Term (years)

    4.9  

Volatility

    123 %

Dividend rate

    0 %

Risk free rate

    4.20 %